| For: | Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY. Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. World J Gastroenterol 2019; 25(6): 719-728 [PMID: 30783375 DOI: 10.3748/wjg.v25.i6.719] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i6/719.htm |
| Number | Citing Articles |
| 1 |
Yue Qiu, Qiao Tang, Xiao-Qing Liu, Yun-Ling Xue, Yi Zeng, Peng Hu. Hepatitis B core-related antigen as a promising serological marker for monitoring hepatitis B virus cure. World Journal of Hepatology 2025; 17(1): 98658 doi: 10.4254/wjh.v17.i1.98658
|
| 2 |
Yandi Xie, Xiaojing Zhang, Xiaozhou Yang, Sujun Zheng, Shuyun Zhang, Xiaoying Zhang, Haiyan Kang, Xuefei Duan, Wenpin Cai, Peng Yin, Xinghuan Ma, Juan liu, Fengmin Lu, Lizhong Dai, Bo Feng. HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-025-04579-3
|
| 3 |
Xin Ji, Muye Xia, Bin Zhou, Shi Liu, GuiChan Liao, Shaohang Cai, Xiaoyong Zhang, Jie Peng. <p>Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog</p>. Infection and Drug Resistance 2020; doi: 10.2147/IDR.S252994
|
| 4 |
Ung Dinh Nguyen, Quyen Le Do, Quynh Anh Nguyen Vu, Nguyet Thi Trieu, Trang Thuy Dao, Nam Van Le, Son Thai Nguyen, Tuyen Tien Hoang, Chinh Trong Nguyen, Thang Hong Nguyen, Dien Van Nguyen, Tho Huu Ho. Selective detection of HBV pre-genomic RNA in chronic hepatitis B patients using a novel RT-PCR assay. Clinical and Experimental Medicine 2023; 23(8) doi: 10.1007/s10238-023-01162-6
|
| 5 |
Yaqin Zhang, Yuanjiao Gao, Xinxin Li, Ziyu Zhang, Shiyu Wang, Zixuan Gao, Yao Xie, Minghui Li. The clinical significance and optimization strategies of HBeAg seroclearance in chronic hepatitis B treatment. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1785154
|
| 6 |
Liandong Wu, Zhenggang Yang, Min Zheng. Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic hepatitis B patients before and after receiving nucleos(t)ide analogues therapy. Journal of Viral Hepatitis 2024; 31(5) doi: 10.1111/jvh.13926
|
| 7 |
Jing Zhou, Xiaoyan Li, Yulin Yang, Xiaomin Wang, Wenhua Xu. Clinical superiority of HBV RNA testing in patients with chronic hepatitis B. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1689229
|
| 8 |
Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, Ruihong Wu, Qinglong Jin, Hongqin Xu, Xiuzhu Gao, Lei Yu, Yuping Chen, Jia Shang, Longgen Liu, Shuqin Zhang, Yongfang Jiang, Mingxiang Zhang, Qiaoxia Tong, Lunli Zhang, Youwen Tan, Anlin Ma, Shuangsuo Dang, Bin Xu, Zhenjing Jin, Jia Li, Xiaobo Li, Fengmin Lu, Junqi Niu. Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks. International Journal of Infectious Diseases 2020; 99 doi: 10.1016/j.ijid.2020.07.031
|
| 9 |
Yachao Tao, Menglan Wang, Juan Liao, Xing Cheng, Min He, Dongmei Zhang, Taoyou Zhou, Jie Chen, Enqiang Chen, Hong Tang. Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.787770
|
| 10 |
Xiao-qi Yu, Ming-jie Wang, De-min Yu, Pei-zhan Chen, Ming-yu Zhu, Wei Huang, Yue Han, Qi-ming Gong, Xin-xin Zhang, Yi-Wei Tang. Comparison of Serum Hepatitis B Virus RNA Levels and Quasispecies Evolution Patterns between Entecavir and Pegylated-Interferon Mono-treatment in Chronic Hepatitis B Patients. Journal of Clinical Microbiology 2020; 58(9) doi: 10.1128/JCM.00075-20
|
| 11 |
Yushuang Zhang, Juanli Wu, Han Gao, Lin Gao, Lei Wang, Tao Li. No Immediate Need for Nucleos(t)ide Analogs Treatment in Untreated Patients With Low-Level Viremia: Evidence From Hepatitis B Virus RNA Levels. Clinical and Translational Gastroenterology 2026; 17(3) doi: 10.14309/ctg.0000000000000970
|
| 12 |
Xuyang Gong, Zhitao Chen, Xiaoxia Zhang, Yi Zheng, Heng Zhang. Effects of Entecavir on Serum Hepatitis B Virus-DNA, Interferon-γ, and Pregenomic RNA in Patients with Chronic Hepatitis B Virus Infection. Hepatitis Monthly 2023; 23(1) doi: 10.5812/hepatmon-132684
|
| 13 |
Matthias Buechter, Arne Maria Günther, Paul Manka, Guido Gerken, Alisan Kahraman. Factors Positively Correlated with Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B. Journal of Personalized Medicine 2024; 14(4) doi: 10.3390/jpm14040390
|
| 14 |
Mohube B. Maepa, Ridhwaanah Jacobs, Fiona van den Berg, Patrick Arbuthnot. Recent developments with advancing gene therapy to treat chronic infection with hepatitis B virus. Current Opinion in HIV and AIDS 2020; 15(3) doi: 10.1097/COH.0000000000000623
|
| 15 |
Yaya Chen, Yuming Yao, Shuo Ma, Meiling Zhou, Jiwei Wang, Gulinaizhaer Abudushalamu, Shijie Cai, Xun Gao, Xiaobo Fan, Guoqiu Wu. Detection of HBV pgRNA by catalytic hairpin assembly combined with two Kinds of immunochromatographic strips. Microchemical Journal 2024; 207 doi: 10.1016/j.microc.2024.112075
|
| 16 |
Guangjun Song, Ruifeng Yang, Qian Jin, Juan Liu, Huiying Rao, Bo Feng, Yandi Xie. HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03023-8
|
| 17 |
Hao Luo, Ning Tan, Qian Kang, Jiali Pan, Hongyu Chen, Hongli Xi, Min Yu, Xiaoyuan Xu. Hepatitis B virus pregenomic RNA status can reveal the long‐term prognoses of chronic hepatitis B patients treated with nucleos(t)ide analogues. Journal of Viral Hepatitis 2020; 27(3) doi: 10.1111/jvh.13227
|
| 18 |
Masanari Kosaka, Hatsue Fujino, Masataka Tsuge, Kenji Yamaoka, Yasutoshi Fujii, Shinsuke Uchikawa, Atsushi Ono, Eisuke Murakami, Tomokazu Kawaoka, Daiki Miki, Clair Nelson Hayes, Seiya Kashiyama, Sho Mokuda, Shinichi Yamazaki, Shiro Oka. Usefulness of serum HBV RNA levels for predicting antiviral response to entecavir treatment in patients with chronic hepatitis B. Journal of Gastroenterology 2025; 60(4) doi: 10.1007/s00535-025-02211-5
|
| 19 |
Zhang Yunzhe, Lei Xuezhong. The Clinical Feature of Chronic Hepatitis B Patients with High HBV pgRNA. Diseases & Research 2023; 3(1) doi: 10.54457/DR.202301001
|
| 20 |
Ting Liu, Yuru Shi, Jing Wu, Linghan Qin, Yingjie Qi. Predictive value of serum HBV RNA on HBeAg seroconversion in treated chronic hepatitis B patients. European Journal of Gastroenterology & Hepatology 2025; 37(6) doi: 10.1097/MEG.0000000000002946
|
| 21 |
Jiali Pan, Jinghang Xu, Hao Luo, Ning Tan, Qian Kang, Hongyu Chen, Ran Cheng, Yifan Han, Yuqing Yang, Xiaoyuan Xu. Factors and virological significance of hepatitis B virus pregenomic RNA status after 5 years of antiviral therapy. International Journal of Infectious Diseases 2021; 105 doi: 10.1016/j.ijid.2021.02.116
|
| 22 |
Xiaojing Zhang, Fengmin Lu, Rui Wu, Qiaofei Jin, Yijun Zhou, Chen Wang, Huaguo Shao, Shourong Liu. Clinical value of serum HBV RNA in patients with chronic hepatitis B during antiviral therapy. PeerJ 2025; 13 doi: 10.7717/peerj.20275
|
| 23 |
Maximilian Wübbolding, Markus Cornberg, Christoph Höner zu Siederdissen. Evidence-Based Approach to Stopping Oral Antiviral Therapy in Chronic HBV. Current Hepatology Reports 2019; 18(4) doi: 10.1007/s11901-019-00502-z
|
| 24 |
Yang Wang, Hao Liao, Zhongping Deng, Yanna Liu, Dandan Bian, Yan Ren, Guangxin Yu, Yingying Jiang, Li Bai, Shuang Liu, Mei Liu, Li Zhou, Yu Chen, Zhongping Duan, Fengmin Lu, Sujun Zheng. Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues. Journal of Viral Hepatitis 2022; 29(6) doi: 10.1111/jvh.13671
|
| 25 |
Yayun Liu, Wei Liao, Aijing Xu, Wei Yin, Jiao Yu, WenHan Fan, Jianya Xue, Xuesong Liang. Early serum HBV RNA combined with HBsAg response can predict HBeAg seroconversation in patients on Entecavir therapy (ClinicalTrials.gov (NCT03909191)). Journal of Infection 2022; 84(4) doi: 10.1016/j.jinf.2022.01.035
|